Does AZD-1222 Cause Immune thrombocytopenia? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Immune thrombocytopenia have been filed in association with AZD-1222. This represents 0.8% of all adverse event reports for AZD-1222.
19
Reports of Immune thrombocytopenia with AZD-1222
0.8%
of all AZD-1222 reports
0
Deaths
13
Hospitalizations
How Dangerous Is Immune thrombocytopenia From AZD-1222?
Of the 19 reports, 13 (68.4%) required hospitalization.
Is Immune thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Immune thrombocytopenia?
RITUXIMAB (335)
ALEMTUZUMAB (299)
PEMBROLIZUMAB (205)
DEXAMETHASONE (202)
ELTROMBOPAG OLAMINE (161)
NIVOLUMAB (151)
ROMIPLOSTIM (145)
OXALIPLATIN (141)
METHOTREXATE (132)
PREDNISONE (127)
Which AZD-1222 Alternatives Have Lower Immune thrombocytopenia Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT